Site Editor

William J. Gradishar, MD, FACP, FASCO


Judy C. Boughey, MD, on What Can Be Learned From I-SPY2 Analysis About Changes in Axillary Surgical Management

Posted: Friday, May 12, 2023

Judy C. Boughey, MD, of the Mayo Clinic, discusses the clinical implications of findings showing that the use of axillary lymph node dissection has declined in the past decade, especially among patients with node-positive breast cancer at diagnosis who had sentinel lymph node surgery after neoadjuvant chemotherapy.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.